Wishing to Decrease Aquaresis in ADPKD Patients Treated With a V2Ra; the Effect of Regulating Protein and Salt

Clinical trial NCT04310319 · UNKNOWN

Trial details

NCT number: NCT04310319
Sponsor: Esther Meijer
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Polycystic Kidney, Autosomal Dominant ADPKD Autosomal Dominant Polycystic Kidney

Start date: 2020-09-07
Primary completion: 2021-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.